NCT01759992

Brief Summary

The global loss of muscle mass and strength associated with aging is a cause of functional impairment and disability, particularly in the older elderly (\>80 years). Respiratory function can be severely compromised if there is a decrease of respiratory (RM) strength complicated by the presence of comorbidities and physical immobility. In this context, the need for supportive services involves the need for long-term care and consequently the institutionalization. Previous studies have shown that the increase of RM strength has positive healthy effects, such as the increase in functional capacity, the decrease in RM fatigue, the decrease of dyspnoea and the improvement of quality of life, both in healthy people and patients. Therefore, specific RM training may be regarded as a beneficial alternative to improve RM function, and thus prevent physical and clinical deterioration in this frail population. Study hypothesis: The inspiratory muscle training (IMT) would improve respiratory muscle strength and endurance, exercise capacity and quality of life in an elderly population, who are unable to engage in general exercise conditioning.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2013

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 31, 2012

Completed
1 day until next milestone

Study Start

First participant enrolled

January 1, 2013

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 3, 2013

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2013

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2013

Completed
Last Updated

March 20, 2014

Status Verified

March 1, 2014

Enrollment Period

6 months

First QC Date

December 31, 2012

Last Update Submit

March 18, 2014

Conditions

Keywords

Frail elderlyMuscle weaknessInstitutionalizationRespiratory muscle training

Outcome Measures

Primary Outcomes (2)

  • Maximum Inspiratory Pressure (MIP)

    MIP is probably the most frequently reported noninvasive estimates of inspiratory muscle strength. Ever since Black and Hyatt (1969) reported this technique it has been widely used in patients, healthy control subjects across all ages, and athletes. Pressure is recorded at the mouth during a quasi-static short (few seconds) maximal inspiration. The manoeuvre is generally performed at Residual Volume (RV). Reference: Am J Respir Crit Care Med. 2002;166:531-535.

    The groups were assessed at baseline (time zero) and at the end of the training protocol (week 9).

  • Maximum Expiratory Pressure (MEP)

    MEP is probably the most frequently reported noninvasive estimates of expiratory muscle strength. Ever since Black and Hyatt (1969) reported this technique it has been widely used in patients, healthy control subjects across all ages, and athletes. Pressure is recorded at the mouth during a quasi-static short (few seconds) maximal expiration. The manoeuvre is generally performed at Total Lung Capacity (TLC). Reference: Am J Respir Crit Care Med. 2002;166:531-535.

    The groups were assessed at baseline (time zero) and at the end of the training protocol (week 9).

Secondary Outcomes (3)

  • Maximal Voluntary Ventilation (MVV)

    The groups were assessed at baseline (time zero) and at the end of the training protocol (week 9).

  • Time performed to walk 10 m distance (10mWT).

    The groups were assessed at baseline (time zero) and at the end of the training protocol (week 9).

  • Maximal heart rate achieved at the end of the incremental arm ergometry test.

    The groups were assessed at baseline (time zero) and at the end of the training protocol (week 9).

Other Outcomes (1)

  • Health-related quality-of-life (CRQ).

    The groups were assessed at baseline (time zero) and at the end of the training protocol (week 9).

Study Arms (2)

Control group

NO INTERVENTION

Usual care

Treatment group

EXPERIMENTAL

Participants will breathe against a load ≥ 50% of their baseline MIP, after which loads will increase according to the participant's tolerance across the remaining training period, using a Borg scale rating of 4 to 6 on perceived exertion as an indicator of adequate training intensity.

Device: Threshold® Inspiratory Muscle Trainer (treatment).

Interventions

Interval-based program consisting of seven cycles of 2-minutes work and 1-minute rest. The sessions will take place 3 times per week over a eight-week period for a total of 24 sessions. All participants were familiarized with the breathing exercises over a two-week familiarization period at the beginning of the protocol. The load will be adjusted at ≥ 50% of baseline MIP.

Also known as: Respironics® Health Scan Inc. Cedar Grove, NJ, USA
Treatment group

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • People aged \> 65 years
  • Barthel Index \< 75 score
  • Mini-mental state examination ≥ 20 score
  • Inspiratory muscle weakness (MIP ≤ 30% predicted value)

You may not qualify if:

  • Ability to independently walk more than 14 m
  • Significant chronic cardiorespiratory diagnoses
  • Acute cardiorespiratory episode during the 2 previous months
  • Neurological, muscular, or neuromuscular problems interfering with the capacity to engage in the tests and training protocol
  • Active smokers or former smokers (\< 5 years)
  • A terminal disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Grupo Gero Residencias "La Saleta"

Valencia, Valencia, 46015, Spain

Location

Related Publications (6)

  • Geddes EL, O'Brien K, Reid WD, Brooks D, Crowe J. Inspiratory muscle training in adults with chronic obstructive pulmonary disease: an update of a systematic review. Respir Med. 2008 Dec;102(12):1715-29. doi: 10.1016/j.rmed.2008.07.005. Epub 2008 Aug 15.

    PMID: 18708282BACKGROUND
  • Gorzoni ML, Pires SL. [Long-term care elderly residents in general hospitals]. Rev Saude Publica. 2006 Dec;40(6):1124-30. doi: 10.1590/s0034-89102006000700024. Portuguese.

    PMID: 17173173BACKGROUND
  • Gosselink R, De Vos J, van den Heuvel SP, Segers J, Decramer M, Kwakkel G. Impact of inspiratory muscle training in patients with COPD: what is the evidence? Eur Respir J. 2011 Feb;37(2):416-25. doi: 10.1183/09031936.00031810.

    PMID: 21282809BACKGROUND
  • Rydwik E, Frandin K, Akner G. Physical training in institutionalized elderly people with multiple diagnoses--a controlled pilot study. Arch Gerontol Geriatr. 2005 Jan-Feb;40(1):29-44. doi: 10.1016/j.archger.2004.05.009.

    PMID: 15531021BACKGROUND
  • Simoes RP, Castello V, Auad MA, Dionisio J, Mazzonetto M. Prevalence of reduced respiratory muscle strength in institutionalized elderly people. Sao Paulo Med J. 2009 May;127(2):78-83. doi: 10.1590/s1516-31802009000200005.

    PMID: 19597682BACKGROUND
  • Watsford M, Murphy A. The effects of respiratory-muscle training on exercise in older women. J Aging Phys Act. 2008 Jul;16(3):245-60. doi: 10.1123/japa.16.3.245.

    PMID: 18660549BACKGROUND

MeSH Terms

Conditions

Muscle WeaknessSyndrome

Interventions

Therapeutics

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsDisease

Study Officials

  • M. Àngels Cebrià i Iranzo, PT, PhD

    University of Valencia

    PRINCIPAL INVESTIGATOR
  • M. Ángeles Tortosa Chuliá, PhD

    University of Valencia

    STUDY CHAIR
  • Celedonia Igual Camacho, PT, PhD

    University of Valencia

    STUDY CHAIR
  • Laura López Bueno, PT, PhD

    University of Valencia

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

December 31, 2012

First Posted

January 3, 2013

Study Start

January 1, 2013

Primary Completion

July 1, 2013

Study Completion

December 1, 2013

Last Updated

March 20, 2014

Record last verified: 2014-03

Locations